Low-dose oral contraceptives: progestin potency, androgenicity, and atherogenic potential.
D000728:Androgens; D001161:Arteriosclerosis / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D011372:Progestins / Q000008:administration & dosage / Q000009:adverse effects*
D000728:Androgens; D003278:Contraceptives, Oral, Hormonal; D004967:Estrogens; D008055:Lipids; D008074:Lipoproteins; D011372:Progestins